Insulet (PODD) Tops Q2 EPS by 21c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mail
Get Alerts PODD Hot Sheet
Price: $133.93 -3.04%
EPS Growth %: +28.2%
Financial Fact:
Research and development: 13.73M
Today's EPS Names:
SPRS, GLDG, PGR, More
EPS Growth %: +28.2%
Financial Fact:
Research and development: 13.73M
Today's EPS Names:
SPRS, GLDG, PGR, More
Join SI Premium – FREE
(Updated - August 5, 2026 7:19 AM EDT)
Insulet (NASDAQ: PODD) reported Q2 EPS of $1.66, $0.21 better than the analyst estimate of $1.45. Revenue for the quarter came in at $801.7 million versus the consensus estimate of $787.82 million.
Raises adjusted EPS growth guidance from >25% to >30%. Cuts FY revenue outlook growth from 21-23% to 20-22%.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Home Bancshares (HOMB) Tops Q3 EPS by 1c
- Goldman Sachs Downgrades ZTO Express (ZTO) to Neutral
- JPMorgan Starts MGE Energy (MGEE) at Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
